SC
SZYM

Steven Cohen’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Steven Cohen’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,707,846
Closed -$12.7M – 879
2014
Q3 		$12.7M Buy
1,707,846
+326,237
+24% +$3.05M 0.1% 244
2014
Q2 		$16.3M Buy
+1,381,609
New +$14.7M 0.1% 237

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Steven Cohen's SZYM Position: Q4 2014 in Review

Steven Cohen sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2014, closing a stake of 1,707,846 shares — an estimated $12.7M sold.

Steven Cohen first reported a position in SZYM in Q2 2014 and held it in 2 quarters. The position peaked at $16.3M in Q2 2014. 114 funds tracked by Wall St. Rank hold SZYM as of Q4 2014.

  • Steven Cohen reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Steven Cohen sold 1,707,846 SOLAZYME INC COM STK (DE) shares in Q4 2014, an estimated $12.7M.
  • Steven Cohen first reported a position in SOLAZYME INC COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • Steven Cohen's SOLAZYME INC COM STK (DE) position peaked at $16.3M in Q2 2014.
  • 114 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2014.

Based on Point72 Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.